Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06917664
PHASE4
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Sponsor: China National Center for Cardiovascular Diseases
View on ClinicalTrials.gov
Summary
This study aims to evaluate the effect of angiotensin receptor/neprilysin inhibitors (ARNI) on improving ischemic mitral regurgitation (IMR) in patients with coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) through a randomized controlled clincial trial.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2025-06-05
Completion Date
2027-06
Last Updated
2025-08-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
sacubitril/valsartan
Sacubitril/valsartan therapy after isolated CABG
Locations (1)
China National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China